Acquired haemophilia A in the postpartum and risk of relapse in subsequent pregnancies: A systematic literature review
- 6 February 2021
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 27 (2), 199-210
- https://doi.org/10.1111/hae.14233
Abstract
Background About 1%–5% of acquired haemophilia A cases affect mothers in the postpartum setting. Aims This study delineates the characteristics of this disease, specific to the postpartum setting, notably relapse in subsequent pregnancies. Methods Report of two cases and literature study (1946–2019), yielding 73 articles describing 174 cases (total 176 cases). Results Patients were aged 29.9 years (17–41) and 69% primigravidae. Diagnosis was made at a median of 60 days after delivery (range 0–308). Bleeding types were obstetrical (43.4%), cutaneous (41.3%), and muscular (36.7%). In >90% of the cases, FVIII at diagnosis was <1% (range 0%–8%). FVIII inhibitor was documented in 75.4% cases (median titre of 20 BU/ml, range 1–621). Haemostatic treatment was necessary in 57.1% using fresh frozen plasma (16%), factor concentrate (27.6%) and/or bypassing agents (37.4%). Immunosuppressive treatment was administered in 90.8%, mostly steroids (85.3%), alone or combined with immunosuppressants (27%). Rituximab was used mostly as a second line treatment. Only 24 patients (13.6%) had documented subsequent pregnancies and 6 (22.2%) suffered haemophilia recurrence during pregnancy. Conclusion This study allows better definition of: (1) clinical and laboratory characteristics of postpartum acquired haemophilia, (2) response to therapy, and (3) the risk of relapse for subsequent pregnancies.Keywords
This publication has 85 references indexed in Scilit:
- Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registryBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012
- The First Case of Postpartum Acquired Hemophilia A in KoreaJournal of Korean Medical Science, 2011
- Postpartum acquired haemophilia: a single centre experience with rituximabHaemophilia, 2009
- Efficacy of rituximab treatment in postpartum acquired haemophilia AHaemophilia, 2007
- Acquired hemophilia A presenting post partumCMAJ : Canadian Medical Association Journal, 2007
- Changes in the occurrence of and risk factors for hemophilia‐associated intracranial hemorrhageAmerican Journal of Hematology, 2001
- Postpartum Acquired Hemophilia (Factor VIII Inhibitors): A Case Report and Review of the LiteratureObstetrical & Gynecological Survey, 2000
- Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VIII:C inhibitorThe Journal of Pediatrics, 1995
- Post-Partum Treatment of a Patient with a Factor VIII InhibitorThe New England Journal of Medicine, 1981